TOTALLY IMPLANTABLE VASCULAR ACCESS FOR HOME ANTIMICROBIAL THERAPY (MEETING ABSTRACT) NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


TOTALLY IMPLANTABLE VASCULAR ACCESS FOR HOME ANTIMICROBIAL THERAPY (MEETING ABSTRACT)

Third International Congress on the Neo-adjuvant Chemotherapy. February 6-9, 1991, Paris, France, p. 40, 1991.. Unique Identifier : AIDSLINE ICDB/92677639
Lucht F; Fresard A; Service des maladies Infectieuses, Chu St Etienne, France


Abstract: Since the early 1980s, the needs of patients (pts) in long-term care increased substantially. These needs appear to be attributable predominantly to pts recently hospitalized for acute conditions rather than pts with chronic debilitating conditions. We have an experience in the treatment of chronic infected pts. We have treated 42 pts (38, chronic Gram-negative bacilli osteomyelitis; 4, AIDS with, respectively, 2 CMV retinitis, and 1 Cryptococcus neoformans meningitis, 1 Candida bacteremia). All the pts received antimicrobial agents via an implantable system ('Port-A-Cath,' Pharmacia). The pts with osteomyelitis received ceftriaxone and pefloxacin for 6-13 mo. Despite oral amphotericin B, 3 of these pts had systemic candidiasis (between 2 and 3 mo after the start of therapy), with septic shock in 3 cases. Since the use of ketoconazole and more recently of fluconazole, we never observed systemic candidiasis. We agree with others that home iv antimicrobial therapy offers several benefits, including cost savings, and that totally implantable venous access systems are safe and comfortable devices for chemotherapy and antiviral therapy. But clinicians must be aware of the major risk of systemic candidiasis when using such systems for long courses of broad-spectrum antimicrobials. Oral ketoconazole or fluconazole may provide valuable prophylaxis against these superinfections. Direct costs and emotional inconvenience are demanding other medical practices such as home iv antibiotic therapy. This practice is feasible with a therapy team, it benefits the pts with a more satisfying life-style, and the community with a better use of acute-care beds and a substantial reduction in hospital costs. A better system of reimbursing for long-term care is required.
Keywords: Ambulatory Care Antibiotics/*ADMINISTRATION & DOSAGE Chronic Disease Home Care Services Human Infection/*DRUG THERAPY *Infusion Pumps, Implantable Osteomyelitis/DRUG THERAPY Patient Care Team Quality of Life ABSTRACT

KWDambulatorycareantibiotics/KWDadministration&dosagechronicdiseasehomecareserviceshumaninfection/KWDdrugtherapyKWDinfusionpumps,implantableosteomyelitis/drugtherapypatientcareteamqualityoflifeabstract
920130
M9210768


Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .